GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

They argue that the current need to use multiple meningococcal vaccines to provide coverage ... That hasn’t stopped Bexsero’s steady growth, with sales approaching the $1 billion threshold ...

“Meningococcal bacteria are all around us in the world ... is spread through contact with saliva from the nose and throat. The newly-developed vaccine, called Bexsero, protects against the B strain of ...

GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...

The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations ...

ULAN BATOR, Feb. 4 (Xinhua) - Mongolia is set to receive 2,000 doses of meningococcal vaccine next week, Health Minister Togtmol Munkhsaikhan said here on Monday. Munkhsaikhan made the remarks while ...

In a major relief for Umrah pilgrims, the Saudi government has suspended the requirement for the meningococcal vaccine, allowing travellers to perform Umrah without this previously mandatory ...

24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...

This information is captured in the table of updates.